Culture and properties of adipose-derived mesenchymal stem cells: characteristics in vitro and immunosuppression in vivo

• Published in: International journal of clinical and experimental pathology 2015-01, Vol.8 (7), p.7694-7709
• Main Authors: Cao, Fujiang, Liu, Tao, Xu, Yunqiang, Xu, Dongdong, Feng, Shiqing
• Format: Article
• Language: English
• Subjects: Adipose Tissue - immunology; Adipose Tissue - metabolism; Adiposity; Animals; Apoptosis; Bone Marrow Cells - immunology; Bone Marrow Cells - metabolism; Cell Line; Cell Proliferation; Disease Models, Animal; Female; Hepatitis - immunology; Hepatitis - therapy; Humans; Immunosuppression; Liver - pathology; Lymphocyte Activation; Mesenchymal Stromal Cells - immunology; Mesenchymal Stromal Cells - metabolism; Mice, Inbred C57BL; Original; Phenotype
• ISSN: 1936-2625

To compare the two sources of adipose and bone marrow derived mesenchymal stem cells (BMSCs and AMSCs) in immune regulation and to evaluate the therapeutic effects of AMSCs on Con A induced hepatitis and the possible mechanism involved in it. We isolated bone marrow and adipose derived mesenchymal stem cells respectively and compared their differences on T lymphocyte activation, proliferation and suppression. We also test the anti-apoptosis ability of AMSCs on LO2 cell line. The effects of intravenous infusion of AMSCs on liver damage were also tested and we detected donor AMSCs in liver of recipient and their effects on the activity of intrahepatic NKT cells. BMSCs and AMSCs were similar in cell phenotype and the difference existed only in the expression of CD106. The results showed that the capacity of suppressing T cells proliferation and activation was weakened in AMSCs. AMSCs ameliorated liver damage and this effect was time and dose dependent. We detected donor AMSCs in liver of recipient which suggested tissue damage could be a clue for AMSCs migration. We also found AMSCs suppress the activity of intrahepatic NKT cells, but this suppress effects was not restricted in liver only, but the whole body. Cell origin and abundance are decisive factors in stem cells applications and with the same premise of AMSCs and BMSCs, adipose tissue is a more promising origin source of stem cells. The immunoregulatory features of MSCs might play an important role in various MSCs cellular therapies.